Mangsbo SM - Search Results

1

Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer.

Sandin LC, Tötterman TH, Mangsbo SM. Sandin LC, et al. Among authors: mangsbo sm. Oncoimmunology. 2014 Jan 1;3(1):e27400. doi: 10.4161/onci.27400. Oncoimmunology. 2014. PMID: 24701374 Free PMC article.

2

CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.

Mangsbo SM, Ninalga C, Essand M, Loskog A, Tötterman TH. Mangsbo SM, et al. J Immunother. 2008 Jan;31(1):34-42. doi: 10.1097/CJI.0b013e3181587d29. J Immunother. 2008. PMID: 18157010

3

Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects.

Mangsbo SM, Sanchez J, Anger K, Lambris JD, Ekdahl KN, Loskog AS, Nilsson B, Tötterman TH. Mangsbo SM, et al. J Immunol. 2009 Nov 15;183(10):6724-32. doi: 10.4049/jimmunol.0902374. Epub 2009 Oct 28. J Immunol. 2009. PMID: 19864604 Free PMC article.

4

Resolvin E1 reduces proinflammatory markers in human pancreatic islets in vitro.

Lund T, Mangsbo SM, Scholz H, Gjorstrup P, Tötterman TH, Korsgren O, Foss A. Lund T, et al. Among authors: mangsbo sm. Exp Clin Endocrinol Diabetes. 2010 Apr;118(4):237-44. doi: 10.1055/s-0029-1241825. Epub 2010 Jan 29. Exp Clin Endocrinol Diabetes. 2010. PMID: 20119897

5

Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.

Mangsbo SM, Sandin LC, Anger K, Korman AJ, Loskog A, Tötterman TH. Mangsbo SM, et al. J Immunother. 2010 Apr;33(3):225-35. doi: 10.1097/CJI.0b013e3181c01fcb. J Immunother. 2010. PMID: 20445343

6

AdCD40L immunogene therapy for bladder carcinoma--the first phase I/IIa trial.

Malmström PU, Loskog AS, Lindqvist CA, Mangsbo SM, Fransson M, Wanders A, Gårdmark T, Tötterman TH. Malmström PU, et al. Among authors: mangsbo sm. Clin Cancer Res. 2010 Jun 15;16(12):3279-87. doi: 10.1158/1078-0432.CCR-10-0385. Epub 2010 May 4. Clin Cancer Res. 2010. PMID: 20448220 Clinical Trial.

7

Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Lindqvist CA, Christiansson LH, Thörn I, Mangsbo S, Paul-Wetterberg G, Sundström C, Tötterman TH, Simonsson B, Enblad G, Frisk P, Olsson-Strömberg U, Loskog AS. Lindqvist CA, et al. Immunology. 2011 Jul;133(3):296-306. doi: 10.1111/j.1365-2567.2011.03439.x. Epub 2011 Apr 5. Immunology. 2011. PMID: 21463298 Free PMC article.

8

T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.

Burman J, Fransson M, Tötterman TH, Fagius J, Mangsbo SM, Loskog AS. Burman J, et al. Among authors: mangsbo sm. Immunology. 2013 Oct;140(2):211-9. doi: 10.1111/imm.12129. Immunology. 2013. PMID: 23721329 Free PMC article.

9

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo.

Sandin LC, Eriksson F, Ellmark P, Loskog AS, Tötterman TH, Mangsbo SM. Sandin LC, et al. Among authors: mangsbo sm. Oncoimmunology. 2014 Jan 1;3(1):e27614. doi: 10.4161/onci.27614. Epub 2014 Jan 16. Oncoimmunology. 2014. PMID: 24701377 Free PMC article.

10

Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer.

Sandin LC, Orlova A, Gustafsson E, Ellmark P, Tolmachev V, Tötterman TH, Mangsbo SM. Sandin LC, et al. Among authors: mangsbo sm. Cancer Immunol Res. 2014 Jan;2(1):80-90. doi: 10.1158/2326-6066.CIR-13-0067. Epub 2013 Oct 21. Cancer Immunol Res. 2014. PMID: 24778163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters